ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sumatriptan Succinate Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-2C8942
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Sumatriptan Succinate Market Insights Forecast to 2028
BUY CHAPTERS

Global Sumatriptan Succinate Market Research Report 2025

Code: QYRE-Auto-2C8942
Report
January 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Pfizer Inc
TEVA
Endo Pharmaceuticals
Mylan NV
Merck
Sun Pharmaceutical

Sumatriptan Succinate Market

The global market for Sumatriptan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Sumatriptan is used to treat acute migraine headaches in adults. It is not used to prevent migraine headaches and is not used for cluster headaches. Sumatriptan works in the brain to relieve the pain from migraine headaches. It belongs to the group of medicines called triptans.
North American market for Sumatriptan Succinate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sumatriptan Succinate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Sumatriptan Succinate include GlaxoSmithKline, Pfizer, Teva, Endo Pharmaceuticals, Mylan, Merck, Sun Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sumatriptan Succinate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sumatriptan Succinate.
The Sumatriptan Succinate market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sumatriptan Succinate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sumatriptan Succinate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sumatriptan Succinate Market Report

Report Metric Details
Report Name Sumatriptan Succinate Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Pfizer, Teva, Endo Pharmaceuticals, Mylan, Merck, Sun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sumatriptan Succinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sumatriptan Succinate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Sumatriptan Succinate Market report?

Ans: The main players in the Sumatriptan Succinate Market are GlaxoSmithKline, Pfizer, Teva, Endo Pharmaceuticals, Mylan, Merck, Sun Pharmaceutical

What are the Application segmentation covered in the Sumatriptan Succinate Market report?

Ans: The Applications covered in the Sumatriptan Succinate Market report are Hospital Pharmacies, Drug Stores

What are the Type segmentation covered in the Sumatriptan Succinate Market report?

Ans: The Types covered in the Sumatriptan Succinate Market report are Tablet, Subcutaneous Injection, Nasal Spray

Recommended Reports

APIs & Tablets

Pain & Migraine

Treatment & Therapy

1 Sumatriptan Succinate Market Overview
1.1 Product Definition
1.2 Sumatriptan Succinate by Type
1.2.1 Global Sumatriptan Succinate Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Subcutaneous Injection
1.2.4 Nasal Spray
1.3 Sumatriptan Succinate by Application
1.3.1 Global Sumatriptan Succinate Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Global Sumatriptan Succinate Market Size Estimates and Forecasts
1.4.1 Global Sumatriptan Succinate Revenue 2020-2031
1.4.2 Global Sumatriptan Succinate Sales 2020-2031
1.4.3 Global Sumatriptan Succinate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sumatriptan Succinate Market Competition by Manufacturers
2.1 Global Sumatriptan Succinate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sumatriptan Succinate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sumatriptan Succinate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sumatriptan Succinate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sumatriptan Succinate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sumatriptan Succinate, Product Type & Application
2.7 Global Key Manufacturers of Sumatriptan Succinate, Date of Enter into This Industry
2.8 Global Sumatriptan Succinate Market Competitive Situation and Trends
2.8.1 Global Sumatriptan Succinate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sumatriptan Succinate Players Market Share by Revenue
2.8.3 Global Sumatriptan Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sumatriptan Succinate Market Scenario by Region
3.1 Global Sumatriptan Succinate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sumatriptan Succinate Sales by Region: 2020-2031
3.2.1 Global Sumatriptan Succinate Sales by Region: 2020-2025
3.2.2 Global Sumatriptan Succinate Sales by Region: 2026-2031
3.3 Global Sumatriptan Succinate Revenue by Region: 2020-2031
3.3.1 Global Sumatriptan Succinate Revenue by Region: 2020-2025
3.3.2 Global Sumatriptan Succinate Revenue by Region: 2026-2031
3.4 North America Sumatriptan Succinate Market Facts & Figures by Country
3.4.1 North America Sumatriptan Succinate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sumatriptan Succinate Sales by Country (2020-2031)
3.4.3 North America Sumatriptan Succinate Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sumatriptan Succinate Market Facts & Figures by Country
3.5.1 Europe Sumatriptan Succinate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sumatriptan Succinate Sales by Country (2020-2031)
3.5.3 Europe Sumatriptan Succinate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sumatriptan Succinate Market Facts & Figures by Region
3.6.1 Asia Pacific Sumatriptan Succinate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sumatriptan Succinate Sales by Region (2020-2031)
3.6.3 Asia Pacific Sumatriptan Succinate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sumatriptan Succinate Market Facts & Figures by Country
3.7.1 Latin America Sumatriptan Succinate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sumatriptan Succinate Sales by Country (2020-2031)
3.7.3 Latin America Sumatriptan Succinate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sumatriptan Succinate Market Facts & Figures by Country
3.8.1 Middle East and Africa Sumatriptan Succinate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sumatriptan Succinate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sumatriptan Succinate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sumatriptan Succinate Sales by Type (2020-2031)
4.1.1 Global Sumatriptan Succinate Sales by Type (2020-2025)
4.1.2 Global Sumatriptan Succinate Sales by Type (2026-2031)
4.1.3 Global Sumatriptan Succinate Sales Market Share by Type (2020-2031)
4.2 Global Sumatriptan Succinate Revenue by Type (2020-2031)
4.2.1 Global Sumatriptan Succinate Revenue by Type (2020-2025)
4.2.2 Global Sumatriptan Succinate Revenue by Type (2026-2031)
4.2.3 Global Sumatriptan Succinate Revenue Market Share by Type (2020-2031)
4.3 Global Sumatriptan Succinate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sumatriptan Succinate Sales by Application (2020-2031)
5.1.1 Global Sumatriptan Succinate Sales by Application (2020-2025)
5.1.2 Global Sumatriptan Succinate Sales by Application (2026-2031)
5.1.3 Global Sumatriptan Succinate Sales Market Share by Application (2020-2031)
5.2 Global Sumatriptan Succinate Revenue by Application (2020-2031)
5.2.1 Global Sumatriptan Succinate Revenue by Application (2020-2025)
5.2.2 Global Sumatriptan Succinate Revenue by Application (2026-2031)
5.2.3 Global Sumatriptan Succinate Revenue Market Share by Application (2020-2031)
5.3 Global Sumatriptan Succinate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Sumatriptan Succinate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Sumatriptan Succinate Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Sumatriptan Succinate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Sumatriptan Succinate Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Sumatriptan Succinate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Sumatriptan Succinate Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Endo Pharmaceuticals
6.4.1 Endo Pharmaceuticals Company Information
6.4.2 Endo Pharmaceuticals Description and Business Overview
6.4.3 Endo Pharmaceuticals Sumatriptan Succinate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Endo Pharmaceuticals Sumatriptan Succinate Product Portfolio
6.4.5 Endo Pharmaceuticals Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Sumatriptan Succinate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Sumatriptan Succinate Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Sumatriptan Succinate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Sumatriptan Succinate Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Sun Pharmaceutical
6.7.1 Sun Pharmaceutical Company Information
6.7.2 Sun Pharmaceutical Description and Business Overview
6.7.3 Sun Pharmaceutical Sumatriptan Succinate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sun Pharmaceutical Sumatriptan Succinate Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sumatriptan Succinate Industry Chain Analysis
7.2 Sumatriptan Succinate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sumatriptan Succinate Production Mode & Process Analysis
7.4 Sumatriptan Succinate Sales and Marketing
7.4.1 Sumatriptan Succinate Sales Channels
7.4.2 Sumatriptan Succinate Distributors
7.5 Sumatriptan Succinate Customer Analysis
8 Sumatriptan Succinate Market Dynamics
8.1 Sumatriptan Succinate Industry Trends
8.2 Sumatriptan Succinate Market Drivers
8.3 Sumatriptan Succinate Market Challenges
8.4 Sumatriptan Succinate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Pfizer Inc
TEVA
Endo Pharmaceuticals
Mylan NV
Merck
Sun Pharmaceutical
List of Tables
 Table 1. Global Sumatriptan Succinate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sumatriptan Succinate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sumatriptan Succinate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sumatriptan Succinate Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Sumatriptan Succinate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sumatriptan Succinate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sumatriptan Succinate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sumatriptan Succinate Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sumatriptan Succinate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sumatriptan Succinate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sumatriptan Succinate, Product Type & Application
 Table 12. Global Key Manufacturers of Sumatriptan Succinate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sumatriptan Succinate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sumatriptan Succinate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sumatriptan Succinate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sumatriptan Succinate Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Sumatriptan Succinate Sales Market Share by Region (2020-2025)
 Table 19. Global Sumatriptan Succinate Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Sumatriptan Succinate Sales Market Share by Region (2026-2031)
 Table 21. Global Sumatriptan Succinate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sumatriptan Succinate Revenue Market Share by Region (2020-2025)
 Table 23. Global Sumatriptan Succinate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sumatriptan Succinate Revenue Market Share by Region (2026-2031)
 Table 25. North America Sumatriptan Succinate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sumatriptan Succinate Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Sumatriptan Succinate Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Sumatriptan Succinate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sumatriptan Succinate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sumatriptan Succinate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sumatriptan Succinate Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Sumatriptan Succinate Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Sumatriptan Succinate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sumatriptan Succinate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sumatriptan Succinate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sumatriptan Succinate Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Sumatriptan Succinate Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Sumatriptan Succinate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sumatriptan Succinate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sumatriptan Succinate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sumatriptan Succinate Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Sumatriptan Succinate Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Sumatriptan Succinate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sumatriptan Succinate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sumatriptan Succinate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sumatriptan Succinate Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Sumatriptan Succinate Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Sumatriptan Succinate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sumatriptan Succinate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sumatriptan Succinate Sales (K Doses) by Type (2020-2025)
 Table 51. Global Sumatriptan Succinate Sales (K Doses) by Type (2026-2031)
 Table 52. Global Sumatriptan Succinate Sales Market Share by Type (2020-2025)
 Table 53. Global Sumatriptan Succinate Sales Market Share by Type (2026-2031)
 Table 54. Global Sumatriptan Succinate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sumatriptan Succinate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sumatriptan Succinate Revenue Market Share by Type (2020-2025)
 Table 57. Global Sumatriptan Succinate Revenue Market Share by Type (2026-2031)
 Table 58. Global Sumatriptan Succinate Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Sumatriptan Succinate Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Sumatriptan Succinate Sales (K Doses) by Application (2020-2025)
 Table 61. Global Sumatriptan Succinate Sales (K Doses) by Application (2026-2031)
 Table 62. Global Sumatriptan Succinate Sales Market Share by Application (2020-2025)
 Table 63. Global Sumatriptan Succinate Sales Market Share by Application (2026-2031)
 Table 64. Global Sumatriptan Succinate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sumatriptan Succinate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sumatriptan Succinate Revenue Market Share by Application (2020-2025)
 Table 67. Global Sumatriptan Succinate Revenue Market Share by Application (2026-2031)
 Table 68. Global Sumatriptan Succinate Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Sumatriptan Succinate Price (US$/Dose) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Sumatriptan Succinate Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Pfizer Sumatriptan Succinate Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Teva Sumatriptan Succinate Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Endo Pharmaceuticals Company Information
 Table 86. Endo Pharmaceuticals Description and Business Overview
 Table 87. Endo Pharmaceuticals Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Endo Pharmaceuticals Sumatriptan Succinate Product
 Table 89. Endo Pharmaceuticals Recent Developments/Updates
 Table 90. Mylan Company Information
 Table 91. Mylan Description and Business Overview
 Table 92. Mylan Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Mylan Sumatriptan Succinate Product
 Table 94. Mylan Recent Developments/Updates
 Table 95. Merck Company Information
 Table 96. Merck Description and Business Overview
 Table 97. Merck Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Merck Sumatriptan Succinate Product
 Table 99. Merck Recent Developments/Updates
 Table 100. Sun Pharmaceutical Company Information
 Table 101. Sun Pharmaceutical Description and Business Overview
 Table 102. Sun Pharmaceutical Sumatriptan Succinate Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Sun Pharmaceutical Sumatriptan Succinate Product
 Table 104. Sun Pharmaceutical Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Sumatriptan Succinate Distributors List
 Table 108. Sumatriptan Succinate Customers List
 Table 109. Sumatriptan Succinate Market Trends
 Table 110. Sumatriptan Succinate Market Drivers
 Table 111. Sumatriptan Succinate Market Challenges
 Table 112. Sumatriptan Succinate Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sumatriptan Succinate
 Figure 2. Global Sumatriptan Succinate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sumatriptan Succinate Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Subcutaneous Injection Product Picture
 Figure 6. Nasal Spray Product Picture
 Figure 7. Global Sumatriptan Succinate Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Sumatriptan Succinate Market Share by Application: 2024 & 2031
 Figure 9. Hospital Pharmacies
 Figure 10. Drug Stores
 Figure 11. Global Sumatriptan Succinate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Sumatriptan Succinate Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Sumatriptan Succinate Sales (2020-2031) & (K Doses)
 Figure 14. Global Sumatriptan Succinate Average Price (US$/Dose) & (2020-2031)
 Figure 15. Sumatriptan Succinate Report Years Considered
 Figure 16. Sumatriptan Succinate Sales Share by Manufacturers in 2024
 Figure 17. Global Sumatriptan Succinate Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Sumatriptan Succinate Players: Market Share by Revenue in Sumatriptan Succinate in 2024
 Figure 19. Sumatriptan Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Sumatriptan Succinate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Sumatriptan Succinate Sales Market Share by Country (2020-2031)
 Figure 22. North America Sumatriptan Succinate Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Sumatriptan Succinate Sales Market Share by Country (2020-2031)
 Figure 26. Europe Sumatriptan Succinate Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Sumatriptan Succinate Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Sumatriptan Succinate Revenue Market Share by Region (2020-2031)
 Figure 34. China Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Sumatriptan Succinate Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Sumatriptan Succinate Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Sumatriptan Succinate Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Sumatriptan Succinate Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Sumatriptan Succinate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Sumatriptan Succinate by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Sumatriptan Succinate by Type (2020-2031)
 Figure 56. Global Sumatriptan Succinate Price (US$/Dose) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Sumatriptan Succinate by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Sumatriptan Succinate by Application (2020-2031)
 Figure 59. Global Sumatriptan Succinate Price (US$/Dose) by Application (2020-2031)
 Figure 60. Sumatriptan Succinate Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Sumatriptan Succinate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lasmiditan Succinate Market Research Report 2025
Global Desvenlafaxine Succinate Market Research Report 2025
Global Zolmitriptan Tablets Market Research Report 2024
Global Tolvaptan Market Research Report 2025
Global Natural Succinic Acid Market Research Report 2025
Global Hydrocortisone Sodium Succinate Market Research Report 2025
Global Solifenacin Succinate Tablets Market Research Report 2024
Global Doxylamine Succinate Market Research Report 2025
Global Triptan Market Insights Forecast to 2030
Global Aprepitant Injection Market Research Report 2025
Global Succinonitrile Market Research Report 2024
Global Sufentanil Citrate Market Research Report 2025
Global N 2 Propynyl succinimide Market Research Report 2025
Metoprolol Succinate Extended Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ribociclib Succinate Market Research Report 2025
Global Rizatriptan Benzoate Market Research Report 2025
Global Valsartan API Market Research Report 2025
Global Sildenafil Citrate Tablets Market Research Report 2024
Global Sulfonate Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions